Piramal may re-enter Indian drug market - News Summed Up

Trending Today


Piramal may re-enter Indian drug market


Photo: BloombergMumbai:The Ajay Piramal-led Piramal Enterprises Ltd (PEL) is considering a re-entry into the domestic formulations business, eight years after selling its portfolio to US-based Abbott Laboratories. “The valuation we got (for domestic formulations business), has not been breached locally. The firm has also merged its financial services units—Piramal Finance and Piramal Capital—under Piramal Housing Finance. Apart from re-entry into the domestic formulations business, the firm is also looking to build its asset management business. The firm’s financial services offerings include housing finance and construction finance, structures loans and loans to large and emerging corporates.


Source: Mint May 28, 2018 15:56 UTC



Loading...
Loading...
  

Loading...